Synthrx - Ownership and Business Overview

Life ScienceCompany

Synthrx Ownership

Who owns Synthrx?

Synthrx is owned by Mast Therapeutics. It was acquired on April 11, 2011.

Synthrx Business Overview

Where is Synthrx headquartered?

Synthrx is headquartered in San Diego, California.

What sector is Synthrx in?

Synthrx is a life science company.

Life Science M&A Summary in 2011

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011. The largest life science acquisition in 2011 was Genzyme - which was acquired by Sanofi SA for $20.1B.

Join Mergr to view all 172 acquisitions of life science companies in 2011, including 24 acquisitions by private equity firms, and 148 by strategics.

Synthrx, Inc.

12390 El Camino Real Suite 150,
San Diego, California 92130
United States,
(858) 552-0866

Synthrx, Inc. is a private biotechnology company developing a purified form of a rheologic and antithrombotic agent, poloxamer 188 (188).


 Subscribe to unlock this and 207,877
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.